iPath Pure Beta Sugar ETN
SGAR
SGAR was delisted on the 11th of April, 2018.
2 hedge funds and large institutions have $61K invested in iPath Pure Beta Sugar ETN in 2015 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
663% more capital invested
Capital invested by funds: $8K → $61K (+$53K)
100% more funds holding
Funds holding: 1 → 2 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$49.7K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.18K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $58K | +$49.7K | +2,610 | +692% |
|
|
TRCT
2
Tower Research Capital (TRC)
New York
| $3K | +$3.18K | +167 | New |
|
SGAR Hedge Fund Activity: Q3 2015 in Review
2 of the 3,583 institutional investors tracked by Wall St. Rank reported a position in iPath Pure Beta Sugar ETN (SGAR) for Q3 2015, worth a combined $61K — up 663% from $8K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new SGAR positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, adding an estimated $49.7K.
- 2 institutional investors held iPath Pure Beta Sugar ETN (SGAR) as of Q3 2015, up from 1 in Q2 2015.
- Funds reported $61K of iPath Pure Beta Sugar ETN stock for Q3 2015, up 663% quarter-over-quarter.
- 1 fund opened new iPath Pure Beta Sugar ETN positions in Q3 2015 and 0 closed out, a net change of +1 holder.
- The largest iPath Pure Beta Sugar ETN buyer in Q3 2015 was UBS Group, an estimated $49.7K added.
Based on aggregated 13F filings for Q3 2015.